Edition:
United Kingdom

Assembly Biosciences Announces FDA Fast Track Designation Granted To ABI-H0731 For Treatment Of Hepatitis B Virus Infection


Wednesday, 25 Jul 2018 

July 25 (Reuters) - Assembly Biosciences Inc ::ASSEMBLY BIOSCIENCES ANNOUNCES FDA FAST TRACK DESIGNATION GRANTED TO ABI-H0731 FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION. 

Company Quote

12.61
 --
21 Aug 2019